- recruitingHuman Pharmacology (Phase I)- Other
An Open-Label, Phase I Clinical Trial to Assess the Effect of a Single Oral Dose of Acalabrutinib on Skin Prick Test Wheal Size in Adults, Aged 18 to 65 years, with Grass Pollen Allergy
This study is looking into a new medicine called acalabrutinib to see if it can help adults with grass pollen allergy. Researchers want to find out if it can reduce the size of allergic skin reactions caused by grass pollen.
Germany - recruiting
GRASS (Grass MATA MPL Real-world Assessment Study)
This study is looking at how a treatment called Grassmuno® works for people with grass pollen allergy in everyday doctor's visits. It's for adults (18 and over) who are already using this treatment for their hay fever or eye allergies caused by grass.
Germany